Literature DB >> 22737627

Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39.

Mickaël Michaud1, Abdul Qader Sukkurwala, Isabelle Martins, Shensi Shen, Laurence Zitvogel, Guido Kroemer.   

Abstract

The efficacy of antineoplastic chemotherapies with anthracyclines or oxaliplatin relies on the induction of immunogenic cell death, thus provoking an anticancer immune response. Recently, we observed that overexpression of CD39, an ATP-degrading enzyme expressed on the cell surface, abolishes the immunogenicity of cell death, thus rendering cancers resistant against chemotherapy.

Entities:  

Year:  2012        PMID： 22737627      PMCID： PMC3382873          DOI： 10.4161/onci.19070

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Richard R Furman; M Johan Broekman; Joan H F Drosopoulos; Harold S Ballard; Kim E Olson; Jorge R Kizer; Aaron J Marcus
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08

2.  Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

Authors:  Aled Clayton; Saly Al-Taei; Jason Webber; Malcolm D Mason; Zsuzsanna Tabi
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

3.  CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.

Authors:  Xiaofeng Sun; Yan Wu; Wenda Gao; Keiichi Enjyoji; Eva Csizmadia; Christa E Müller; Takashi Murakami; Simon C Robson
Journal:  Gastroenterology       Date:  2010-06-25       Impact factor: 22.682

Review 4.  Immune parameters affecting the efficacy of chemotherapeutic regimens.

Authors:  Laurence Zitvogel; Oliver Kepp; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

5.  Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

Authors:  Mickaël Michaud; Isabelle Martins; Abdul Qader Sukkurwala; Sandy Adjemian; Yuting Ma; Patrizia Pellegatti; Shensi Shen; Oliver Kepp; Marie Scoazec; Grégoire Mignot; Santiago Rello-Varona; Maximilien Tailler; Laurie Menger; Erika Vacchelli; Lorenzo Galluzzi; François Ghiringhelli; Francesco di Virgilio; Laurence Zitvogel; Guido Kroemer
Journal:  Science       Date:  2011-12-16       Impact factor: 47.728

Review 6.  Extracellular adenosine triphosphate and adenosine in cancer.

Authors:  J Stagg; M J Smyth
Journal:  Oncogene       Date:  2010-07-26       Impact factor: 9.867

Review 7.  Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.

Authors:  Aaron J Marcus; M Johan Broekman; Joan H F Drosopoulos; Naziba Islam; David J Pinsky; Casilde Sesti; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

8.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Authors:  François Ghiringhelli; Lionel Apetoh; Antoine Tesniere; Laetitia Aymeric; Yuting Ma; Carla Ortiz; Karim Vermaelen; Theocharis Panaretakis; Grégoire Mignot; Evelyn Ullrich; Jean-Luc Perfettini; Frédéric Schlemmer; Ezgi Tasdemir; Martin Uhl; Pierre Génin; Ahmet Civas; Bernhard Ryffel; Jean Kanellopoulos; Jürg Tschopp; Fabrice André; Rosette Lidereau; Nicole M McLaughlin; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

9.  Chemotherapy induces ATP release from tumor cells.

Authors:  Isabelle Martins; Antoine Tesniere; Oliver Kepp; Mickael Michaud; Frederic Schlemmer; Laura Senovilla; Claire Séror; Didier Métivier; Jean-Luc Perfettini; Laurence Zitvogel; Guido Kroemer
Journal:  Cell Cycle       Date:  2009-11-08       Impact factor: 4.534

10.  Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Authors:  Magis Mandapathil; Miroslaw J Szczepanski; Marta Szajnik; Jin Ren; Diana E Lenzner; Edwin K Jackson; Elieser Gorelik; Stephan Lang; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531
  10 in total
  31 in total

1.  Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis.

Authors:  Abhishek D Garg; Dirk De Ruysscher; Patrizia Agostinis
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 2.  Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

Authors:  Jonathan Pol; Erika Vacchelli; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 3.  Advancing Immunotherapy in Metastatic Breast Cancer.

Authors:  Mariam Mansour; Zhi Ling Teo; Stephen J Luen; Sherene Loi
Journal:  Curr Treat Options Oncol       Date:  2017-06

Review 4.  Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.

Authors:  Henri-Alexandre Michaud; Jean-François Eliaou; Virginie Lafont; Nathalie Bonnefoy; Laurent Gros
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

5.  Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.

Authors:  So-Jin Park; Wenda Ye; Roy Xiao; Christopher Silvin; Michelle Padget; James W Hodge; Carter Van Waes; Nicole C Schmitt
Journal:  Oral Oncol       Date:  2019-06-20       Impact factor: 5.337

6.  Molecular mechanisms of ATP secretion during immunogenic cell death.

Authors:  I Martins; Y Wang; M Michaud; Y Ma; A Q Sukkurwala; S Shen; O Kepp; D Métivier; L Galluzzi; J-L Perfettini; L Zitvogel; G Kroemer
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

Review 7.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

Review 8.  Big opportunities for small molecules in immuno-oncology.

Authors:  Jerry L Adams; James Smothers; Roopa Srinivasan; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2015-07-31       Impact factor: 84.694

Review 9.  Danger signalling during cancer cell death: origins, plasticity and regulation.

Authors:  A D Garg; S Martin; J Golab; P Agostinis
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

Review 10.  Consensus guidelines for the detection of immunogenic cell death.

Authors:  Oliver Kepp; Laura Senovilla; Ilio Vitale; Erika Vacchelli; Sandy Adjemian; Patrizia Agostinis; Lionel Apetoh; Fernando Aranda; Vincenzo Barnaba; Norma Bloy; Laura Bracci; Karine Breckpot; David Brough; Aitziber Buqué; Maria G Castro; Mara Cirone; Maria I Colombo; Isabelle Cremer; Sandra Demaria; Luciana Dini; Aristides G Eliopoulos; Alberto Faggioni; Silvia C Formenti; Jitka Fučíková; Lucia Gabriele; Udo S Gaipl; Jérôme Galon; Abhishek Garg; François Ghiringhelli; Nathalia A Giese; Zong Sheng Guo; Akseli Hemminki; Martin Herrmann; James W Hodge; Stefan Holdenrieder; Jamie Honeychurch; Hong-Min Hu; Xing Huang; Tim M Illidge; Koji Kono; Mladen Korbelik; Dmitri V Krysko; Sherene Loi; Pedro R Lowenstein; Enrico Lugli; Yuting Ma; Frank Madeo; Angelo A Manfredi; Isabelle Martins; Domenico Mavilio; Laurie Menger; Nicolò Merendino; Michael Michaud; Gregoire Mignot; Karen L Mossman; Gabriele Multhoff; Rudolf Oehler; Fabio Palombo; Theocharis Panaretakis; Jonathan Pol; Enrico Proietti; Jean-Ehrland Ricci; Chiara Riganti; Patrizia Rovere-Querini; Anna Rubartelli; Antonella Sistigu; Mark J Smyth; Juergen Sonnemann; Radek Spisek; John Stagg; Abdul Qader Sukkurwala; Eric Tartour; Andrew Thorburn; Stephen H Thorne; Peter Vandenabeele; Francesca Velotti; Samuel T Workenhe; Haining Yang; Wei-Xing Zong; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.